In One Sentence: Retatrutide, also known as Triple G, is a once-weekly injectable medication currently being researched for weight loss and Type 2 diabetes, showing promising results in early studies by targeting multiple metabolic pathways involved in appetite control and fat metabolism
Wegovy is available for obesity under NHS specialist criteria
The FDA-approved injection sites for most of these medications include three primary areas: the abdomen, the front of the thighs, and the upper arms (though upper arm injections often require administration by another person)
Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry
The Ozempic baby phenomenon As ovulation returns and cycles become more regular, some women on GLP-1 medications have experienced unexpected pregnancies sometimes called Ozempic babies. This can happen because weight loss and improved insulin sensitivity may restore ovulation in previously anovulatory patients, especially those with PMOS (formerly PCOS)
And we say, hey look, this is where we are now